Hybrid Imaging Modalities for the Evaluation of Infection

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT00230152
• Date of registration: 29/09/2005
• Prospective Registration: Yes
• Primary sponsor: Rambam Health Care Campus
• Public title: Hybrid Imaging Modalities for the Evaluation of Infection
• Scientific title: Nuclear Medicine for the Evaluation of Infection-the Added Value of Hybrid Imaging Modalities
• Date of first enrolment: February 2006
• Target sample size: 300
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT00230152
• Study type: Interventional
• Study design: Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
• Phase: N/A

Countries of recruitment

Israel

Contacts

• Name: Zohar Keidar, MD, PhD
• Affiliation: Rambam Health Care Campus

Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients referred for NM imaging procedures to assess the presence of infectious
processes.

- Patients signed informed consent

Exclusion Criteria:

- The study will not be performed in pregnant or lactating women.

- Patients unable or unwilling to tolerate the scan until its completion



Age minimum: 18 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Infectious Diseases

Intervention(s)

Device: Imaging

Primary Outcome(s)

The impact of the imaging modality on patient management [Time Frame: 3 years]

Secondary Outcome(s)

The impact of the imaging modality on patient management [Time Frame: 2 years]

Secondary ID(s)

infectionCTIL

Source(s) of Monetary Support

Please refer to primary and secondary sponsors